Advertisements

Nuelin SR

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nuelin SR

Property Description
Active ingredient Choline Theophyllinate
Form Sustained-Release Tablet (Oral)
Pharmacological class Bronchodilator, Methylxanthine derivative
General purpose To reduce airflow obstruction
Origin Synthetic derivative

What Type of Medicine is Nuelin SR and What is it Made Of?

Nuelin SR is a prescription-only medicine administered as an oral dosage form, categorized as a Bronchodilator belonging to the Methylxanthine family of drugs. Its active ingredient is Choline Theophyllinate, which is a single-ingredient salt designed to deliver Theophylline anhydrous, the active component. Choline Theophyllinate is a synthetic derivative of theophylline, a naturally occurring alkaloid. The efficacy of methylxanthines in managing respiratory conditions is recognized for their role in reducing airway resistance.

The Role of the Sustained-Release (SR) Tablet Design

Unlike immediate-release formulations, the designation SR signifies that Nuelin SR is a Modified-Release Tablet, an Oral Dosage Form specifically engineered to be a Sustained-Release Tablet. This design utilizes specialized solid oral matrix components to control the slow-release of the active substance, Choline Theophyllinate, gradually over many hours. The purpose of this controlled delivery mechanism is to help maintain consistent and stable therapeutic levels of Theophylline in the bloodstream, providing prolonged action.

General Benefit and Purpose

The fundamental action of Nuelin SR is to achieve smooth muscle relaxation within the bronchial passages, which constitutes its primary bronchodilator effect. The result of this action is a functional widening of the airways. Its general purpose is therefore to reduce airflow obstruction and resistance in the lungs, thereby making breathing easier and less labored for individuals experiencing reversible airway constriction.

Regulatory References

  1. Theophylline Information
Advertisements

What side effects are possible with Nuelin SR?

Possible Side Effects and Safety Information

The officially documented safety profile for Nuelin SR (Choline Theophyllinate) is defined by adverse reactions related to its active component, theophylline, and its classification as a drug with a narrow therapeutic index.

Adverse effects are broadly categorized by the affected system-organ classes, primarily the gastrointestinal, nervous, and cardiovascular systems. Common reported reactions, as classified in regulatory documents, include headache, insomnia (difficulty sleeping), nausea, vomiting, and stomach irritation. These effects often relate to the stimulating properties of methylxanthine drugs.

The frequency and severity of adverse reactions are directly linked to the drug's concentration in the bloodstream. The risk for serious effects increases substantially when the serum theophylline concentration exceeds 20 mu g/ mL. Serious adverse reactions documented in official labeling include life-threatening cardiac arrhythmias and convulsions (seizures).

Population-specific safety considerations are mandated by regulatory authorities. Caution and close monitoring are required for older adults and patients with established hepatic impairment, cardiac disease, or a history of seizure disorders. These conditions can decrease the body's clearance of theophylline, which elevates the risk of toxicity. Conditions such as fever or viral infections may also reduce clearance and require clinical attention.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Nuelin SR (Choline Theophyllinate) results in toxicity primarily related to its active component, Theophylline, as documented in regulatory prescribing information. The clinical presentation may range from mild to severe and is defined by effects on multiple physiological systems.

Documented Overdose Manifestations

Initial signs may include gastrointestinal distress (nausea, persistent vomiting, abdominal pain) and neurological symptoms (tremors, headache, restlessness). As toxicity escalates, more serious manifestations can occur, including seizures and severe cardiac arrhythmias (e.g., ventricular tachycardia), which are life-threatening events. Disturbances in metabolic status, such as hypokalemia and metabolic acidosis, are also documented regulatory findings.

When to Seek Urgent Medical Help

Official labeling mandates that immediate medical attention must be sought upon any suspicion of overdose or accidental ingestion. Due to the sustained-release (SR) formulation, toxicity may be delayed, and severe complications can emerge abruptly without preceding milder symptoms. Emergency services should be contacted right away. There is no specific antidote known for theophylline toxicity; management involves immediate supportive and symptomatic care, including the potential use of activated charcoal, intensive monitoring, and, in severe cases, procedures like hemodialysis. Increased risk of severe outcomes is noted for the very young, the elderly, and patients with conditions like hepatic cirrhosis.

Advertisements

Therapeutic Uses of Nuelin SR

What Nuelin SR Treats: Main Uses and Benefits

Nuelin SR is a medication prescribed to support the management of certain respiratory conditions characterized by reversible airway narrowing, also known as bronchospasm. The primary goal of treatment is to help patients breathe more easily and experience a reduction in chest tightness and wheezing. It is commonly used for the maintenance of relief and the long-term control of symptoms associated with bronchial asthma, chronic bronchitis, and emphysema.

This medication is not intended for the rapid relief of acute, sudden breathing difficulties; a different 'reliever' medication should be used in those situations. Its slow-release formulation is designed to provide sustained support for breathing over a 12-hour duration, contributing to symptom control over time.

Quick Fact: Sustained Support for Breathing

Clinical use is focused on reducing the severity of symptoms related to:

  • Bronchial asthma
  • Chronic bronchitis
  • Emphysema
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Status

Regulatory agencies define the population eligibility for Nuelin SR (Choline Theophyllinate/Theophylline) based on patient health status, age, and potential for altered drug clearance.

Classification Population/Condition
Absolute Contraindication Hypersensitivity to Theophylline or other xanthine derivatives (e.g., caffeine), active peptic ulcer disease, or pre-existing seizure disorders.
Conditional/Restricted Use Impaired liver function (e.g., cirrhosis), severe cardiac disease (e.g., arrhythmias, heart failure), high blood pressure, or acute viral illness with fever.
Not Recommended The tablet formulation is generally not recommended for children under two years of age.

Age and Clearance Constraints

Use is established for adults and children over two years (with dosage adjusted by body weight). However, elderly patients are classified as a restricted-use group because their clearance of the medicine is often decreased, increasing the potential for accumulation. The drug is present in breast milk, and clearance is altered in pregnant women, especially during the third trimester, placing these populations in a conditional use category.

Advertisements

What should I know about interactions with other medicines?

Nuelin SR Interactions with other medicines and products

The interaction profile for Nuelin SR (Theophylline) is defined by official regulatory documentation that highlights substances capable of altering the drug's plasma exposure or creating additive effects, resulting in specific administration constraints.


Formal Regulatory Restrictions

Specific drug combinations are formally classified as either contraindicated or require mandatory separation:

  • Contraindicated Combinations: Co-administration with Riociguat is explicitly prohibited due to the risk of severe hypotension stemming from documented additive pharmacodynamic effects. Use with Febuxostat or other Xanthine derivatives is also strictly contraindicated, as these substances significantly increase Theophylline plasma concentrations.
  • Timing Rule: The drug Dipyridamole is subject to a specific timing constraint for thallium imaging procedures and must be separated by at least 24 hours, as officially documented in regulatory labeling.

Pharmacokinetic Clearance Interactions

Many documented interactions involve pharmacokinetic alteration, where other substances change the rate at which Theophylline is cleared from the body, impacting its circulating levels:

  • Increased Exposure: Enzyme inhibitors such as Ciprofloxacin, Fluvoxamine, and Cimetidine are documented to decrease Theophylline clearance, which results in elevated plasma concentrations.
  • Decreased Exposure: Enzyme inducers like Rifampicin, Phenytoin, and Carbamazepine are documented to increase Theophylline clearance, reducing the drug’s concentration in the body.
  • Substance Interactions: Tobacco Smoking, Alcohol consumption, and the herbal product St John’s Wort are officially documented as causing increased clearance. Regulatory labeling also identifies Elderly patients and those with Hepatic Impairment as populations having reduced baseline Theophylline clearance, which amplifies the risk of clearance-reducing interactions.
Advertisements

Mechanism of Action

Modulation of Cellular Signaling via Enzyme Inhibition

The primary mechanism involves the non-selective inhibition of Phosphodiesterase (PDE) enzymes ( PDE3 and PDE4), which are responsible for breaking down the cellular messenger cyclic AMP ( cAMP). By preventing the degradation of cAMP, the drug elevates its concentration within bronchial smooth muscle cells. This action initiates a molecular cascade that lowers the internal calcium concentration, leading directly to smooth muscle relaxation and a subsequent reduction in airway smooth muscle tone.

Regulation of Airway Reactivity and Inflammatory Signaling

Nuelin SR also acts by antagonizing Adenosine Receptors (A1, A2A, A2B), thereby blocking an endogenous signal that promotes airway smooth muscle tone and the release of pro-inflammatory mediators. Additionally, the drug indirectly modulates the expression of inflammatory genes by promoting the activity of Histone Deacetylase 2 ( HDAC2), an enzyme critical for suppressing the transcription of pro-inflammatory genes. These dual actions result in an alteration of airway reactivity and a systemic reduction in inflammatory mediator transcription within the respiratory system.

Modulation of Respiratory Muscle Mechanics

Beyond its local effects on the bronchial tubes, the drug's mechanism extends to influencing systemic skeletal muscle function. It increases the contractile force of the diaphragm by modulating calcium handling within the muscle cells. This action constitutes a direct modulation of skeletal muscle contractility within the respiratory system.

Advertisements

Dosage and Administration Information

Administration Guidelines

This section details the usage principles for Nuelin SR (Choline Theophyllinate sustained-release tablets).

Feature Instruction
Route of administration Oral administration only. The sustained-release tablets must be swallowed whole to ensure the controlled release of the active substance.
Dosing schedule Dosage is individually titrated to maintain a target serum Theophylline concentration of 10 to 20 mcg/mL. A common starting adult dose is 250 mg every twelve hours.
Timing in relation to meals Must be taken with or immediately after food to mitigate potential gastrointestinal irritation and ensure proper absorption.
Preparation requirements The tablets must not be chewed or crushed and are to be taken with a full glass of water.
Age-group rules Not recommended for children under 2 years. Dosing for children over 2 years is calculated based on body weight. The dose for older adults is typically lower than the maximum adult dose.
Missed-dose rules Patients must not take a double dose to compensate for a missed dose. The standard schedule should be resumed immediately.

Connection to the Overall Use Protocol

The use protocol for Nuelin SR requires strictly oral administration on a twice-daily schedule. This structured approach is essential because the medicine is a sustained-release formulation, requiring consistent timing and no alteration of the tablet form to ensure a steady release of the active component. Dosage adjustments are guided by Therapeutic Drug Monitoring (TDM), adjusting the amount taken at intervals of no less than three days to confirm the dose maintains the therapeutic range.

Advertisements

Recent Clinical Evidence

Research Evidence: Nuelin SR (Theophylline)

Nuelin SR contains theophylline, a methylxanthine derivative used in the management of reversible bronchospasm associated with asthma and Chronic Obstructive Pulmonary Disease (COPD). Recent clinical studies have focused primarily on the role of sustained-release theophylline as an add-on therapy and its anti-inflammatory effects, particularly at lower concentrations.

Efficacy in COPD and Asthma

Clinical trials and systematic reviews indicate that oral theophylline, including sustained-release formulations, can lead to statistically significant improvements in lung function measures for patients with stable COPD. Key findings include:

  • Forced Expiratory Volume in 1 second ( FEV1): Meta-analyses show that theophylline use, often in combination with inhaled beta2-agonists, is associated with a measurable improvement in FEV1 compared to placebo in stable COPD patients.
  • Dyspnea: Studies have also observed an improvement in self-reported measures of shortness of breath (dyspnea) when theophylline is added to a patient’s regimen, particularly when compared to theophylline alone.

Tolerability and Safety Profile

Due to its narrow therapeutic index, theophylline requires therapeutic drug monitoring to maintain plasma concentrations within the accepted therapeutic range (typically 10 –20 mg/L for bronchodilation or sometimes lower for anti-inflammatory effects). Clinical data indicates:

  • Side Effects: The use of theophylline is commonly associated with adverse effects, particularly gastrointestinal issues (nausea, vomiting) and central nervous system stimulation (headache, insomnia, tremor), which are more pronounced at higher serum concentrations.
  • Risk: The potential for serious cardiac arrhythmias and seizures at toxic concentrations necessitates careful individualized dose titration, especially in patients with underlying cardiac, liver, or renal conditions, or in elderly individuals.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nuelin SR (FAQ)


Q: What is the difference between Nuelin SR and standard Nuelin tablets?

A: The key difference is how the active substance, theophylline, is released. Nuelin SR is a sustained-release formulation, meaning it is designed to release the medicine slowly over an extended period. Standard, or immediate-release, tablets release the medicine all at once. The sustained-release design is often associated with less frequent dosing.


Q: How quickly should I notice any effects from Nuelin SR?

A: Official information indicates that Nuelin SR is a long-term, maintenance treatment. It requires consistent daily use to build up and maintain a stable therapeutic level in the blood. Regulatory information states it is not intended for the relief of acute, severe respiratory symptoms.


Q: Does Nuelin SR make you sleepy or drowsy?

A: No, Nuelin SR is generally not associated with drowsiness. In fact, regulatory documents state that theophylline, its active ingredient, can stimulate the central nervous system. Side effects such as restlessness, insomnia, or trouble sleeping are sometimes reported.


Q: Can Nuelin SR cause stomach upset or nausea?

A: Yes, common side effects of theophylline include gastrointestinal discomfort such as nausea, vomiting, or stomach pain. Regulatory guidance advises the medicine may be taken with or immediately after food. This is intended to help reduce the potential for irritation in the stomach.


Q: Is it normal to have a headache when first starting Nuelin SR?

A: Headache is listed among the commonly reported side effects in official product information. These effects are often related to the initial adjustment period as the body gets used to the medicine. These effects may sometimes lessen as the individual adjusts to the medication.


Q: Is Nuelin SR used for anxiety or panic attacks?

A: No, Nuelin SR is indicated for the maintenance treatment of chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). According to the official therapeutic indications, it is not used or indicated for the treatment of anxiety or panic attacks.


Q: Are there any common foods or drinks to avoid while taking Nuelin SR?

A: Official guidance suggests limiting or avoiding consumption of products that contain high amounts of caffeine. Theophylline is chemically similar to caffeine, and consuming both together may increase the possibility of side effects such as nervousness or trouble sleeping.


Q: Can Nuelin SR affect my sleep pattern?

A: Yes, because theophylline acts as a central nervous system stimulant, it may affect your sleep. Regulatory documents list sleep disturbances, restlessness, and insomnia as potential side effects.


Q: Is Nuelin SR a prescription-only medicine?

A: Yes, the active ingredient in Nuelin SR, theophylline, is classified as a prescription-only medicine in most regulatory jurisdictions. It requires a valid prescription from an authorized healthcare professional.


Q: Is Nuelin SR considered safe for long-term use?

A: Theophylline is an established medication used as a long-term control therapy for chronic respiratory diseases. Due to its nature, its long-term use requires ongoing monitoring, often through blood tests, to maintain the concentration within the established therapeutic range.


Q: Do studies suggest Nuelin SR is effective for severe symptoms?

A: Theophylline is widely accepted as a maintenance bronchodilator for respiratory conditions. Regulatory documents state it is not indicated for the relief of acute, severe respiratory symptoms and is not intended to be used as a 'rescue' medicine.


Q: Can elderly people use Nuelin SR?

A: Yes, theophylline may be used by older adults. Official information states that a lower dose may be necessary due to possible changes in metabolism. Closer monitoring of blood levels may also be required.


Q: Can Nuelin SR interact with herbal supplements?

A: Yes, regulatory information warns that certain herbal products can interact with theophylline. For example, St John’s wort is listed as a product that may affect how quickly the drug is processed by the body. This may change the medicine's concentration in the blood.


Q: Is Nuelin SR a controlled substance?

A: No, theophylline, the active ingredient in Nuelin SR, is not classified as a controlled substance in most major regulatory jurisdictions. It is not associated with a risk of addiction or dependence.


Q: What happens if I stop taking Nuelin SR suddenly?

A: Nuelin SR is used to maintain long-term control of chronic respiratory symptoms. Stopping the medicine suddenly can lead to a loss of symptom control. Any decision to change treatment requires discussion with a healthcare professional.


Q: Is Nuelin SR suitable for someone who smokes?

A: Tobacco smoking is known to significantly affect how quickly theophylline is cleared from the body. Because of this interaction, smokers may require a higher dose than non-smokers to maintain effective levels. Dose adjustment is generally necessary if an individual's smoking status changes.


Q: How long does the effect of one dose of Nuelin SR typically last?

A: Nuelin SR is a sustained-release formulation designed to provide a continuous level of theophylline in the blood. The sustained-release formulation is intended to provide therapeutic levels for approximately 12 hours.


Q: Is there a generic version of Nuelin SR available?

A: Yes, the active substance, theophylline, is an older medicine and is available in generic formulations. This includes other sustained-release preparations of theophylline, which may be available depending on the region.


Q: Are there any known severe side effects of Nuelin SR?

A: Serious adverse effects have been reported, primarily if the concentration of theophylline in the blood becomes too high. These effects, such as seizures or severe vomiting, necessitate prompt medical evaluation.


Q: Does Nuelin SR have a risk of addiction or dependence?

A: No, Nuelin SR is not classified as a controlled substance and is not associated with a risk of addiction or dependence.


Q: How is the safety of Nuelin SR monitored by health authorities?

A: Health authorities continually monitor the safety of Nuelin SR and other medicines through national pharmacovigilance programs. These programs collect reports of suspected adverse reactions from healthcare professionals and patients to ensure the safety profile of the medicine is continuously assessed.


Q: Is it possible for Nuelin SR to cause allergic reactions?

A: Yes, the medicine is officially contraindicated, or not to be used, in individuals who have a known hypersensitivity or allergy to theophylline, aminophylline, or caffeine. Allergic reactions, such as severe rash or swelling, are possible.


Q: Can Nuelin SR make existing tremor or nervousness worse?

A: Theophylline is a stimulant, and nervousness, restlessness, and muscle tremor are listed as common side effects. Therefore, the use of Nuelin SR may potentially exacerbate existing symptoms of tremor or nervousness.


Q: What kind of research has been done on Nuelin SR?

A: Research has focused on theophylline's fundamental mechanism in the body. This includes studies on its ability to relax bronchial smooth muscles, its inhibition of certain enzymes (phosphodiesterases), and its effect on blocking the action of adenosine receptors.


Q: Are there any restrictions on driving while taking Nuelin SR?

A: Official information advises that certain side effects, such as dizziness, confusion, or visual disturbances, could affect a patient's ability to drive or operate machinery. Individuals are encouraged to be aware of their personal reaction to the medication before driving or operating machinery.


Q: Can Nuelin SR affect my blood pressure?

A: Theophylline has been reported to cause cardiovascular effects, including changes in heart rate and sometimes blood pressure. Regulatory guidance advises caution when the medicine is used in patients with pre-existing cardiovascular conditions.


Q: Is Nuelin SR a relatively new or old medicine?

A: The active substance in Nuelin SR, theophylline, is considered an established medicine that has been used in medical practice for over a century. The sustained-release formulation, however, represents a later development designed to improve dosing and consistency.


Q: Does Nuelin SR contain gluten or lactose?

A: This information is specific to the inactive ingredients used in the exact formulation of the tablet. The full list of excipients, which specifies if common substances like gluten or lactose are present, is provided in the official product information.


Q: What is the consensus in the medical community about Nuelin SR?

A: Theophylline is generally regarded as an accepted, established maintenance treatment for chronic respiratory diseases. Current professional guidelines typically position it as an alternative or add-on therapy, rather than a primary first-line treatment.


Q: Can Nuelin SR be taken with antacids or heartburn medication?

A: Some regulatory sources advise caution regarding certain medications, including some antacids, that can alter theophylline's absorption or how it is metabolized. If taking these, closer monitoring of the theophylline dose may be needed.


Q: Does Nuelin SR lose effectiveness over time?

A: Official information does not indicate that the medicine itself loses effectiveness or that patients develop tolerance to it. However, changes in other factors, such as smoking status or new interacting medicines, can change the effective concentration of the drug, which may necessitate a dose adjustment.


Q: Is Nuelin SR safe to use during pregnancy?

A: Theophylline is known to pass through the placenta. Official warnings state that studies in humans are often limited or inadequate. Regulatory documents note that the medicine may be used during pregnancy only after careful assessment of the clinical situation, as increased monitoring of blood levels is required.


Q: Can Nuelin SR affect the liver or kidneys?

A: Theophylline is processed primarily by the liver. Official warnings state that its clearance may be significantly reduced in patients with impaired liver function, such as cirrhosis. Dose adjustments and close monitoring are often required in cases of significant liver or kidney dysfunction to prevent toxicity.


Q: What are the most commonly reported side effects in studies of Nuelin SR?

A: Official safety data indicates the most frequently reported side effects involve the gastrointestinal system (such as nausea and stomach pain) and the central nervous system (such as headache, trouble sleeping, and restlessness).


Q: Why might a doctor switch me from an immediate-release version to Nuelin SR?

A: A switch to the sustained-release (SR) formulation is often made to achieve a more steady, consistent concentration of the medicine in the blood over a 24-hour period. This consistent level may reduce the risk of side effects associated with high peak concentrations and is associated with less frequent daily dosing.

Advertisements

How should Nuelin SR be stored and disposed of?

Storage and Disposal of Nuelin SR

Official regulatory labeling dictates specific conditions for storing Nuelin SR tablets to maintain product integrity and safety.

Storage Requirements

Condition Requirement
Temperature Store below 30 C (or 25 C as specified by some local labels).
Protection Keep in a cool, dry place, protected from moisture, heat, and direct sunlight.
Container Must be kept in the original container until the time of use and should not be used past the printed expiry date.
Child Safety Store the medicine out of the sight and reach of children.

Disposal Instructions

Unwanted, expired, or unused Nuelin SR tablets must be handled according to specific pharmaceutical waste protocols. Regulatory guidance requires that the medicine be returned to a pharmacy for safe disposal. The tablets must not be disposed of via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nuelin SR found in:

A-Z Index: